Top Story
MedPAC recommends composite rate update for ESRD program
FEATURES
Week in Review
(3/5) 
NxStage continues to move through Europe, Fresenius keeps growing
Top stories for March 1 to 5
Week in Review
(2/26) 
Home dialysis market grows, so does the possibility of more acquisitions
Top stories for Feb. 22 to 27
Week in Review
(2/19) 
Hope for two investigational immunosuppressants
Top stories for Feb. 15 to 19
Week in Review
(2/12) 
HHS releases report on catastrophic health events
Top stories for Feb. 8 to 12
Week in Review
(2/5) 
The System One continues global spread
The top stories for Feb. 1 to 5
E-POLL
Have you/your dialysis company scaled back plans to expand or buy other clinics because of the potential impact of the ESRD payment bundle?

Yes
No
 
  » View Results
  » View Past Polls
LATEST NEWS
BLOGS
Health Care Beat
By Rebecca Zumoff
Business as usual: MedPAC report shows in-center dialysis remains a profitable business
QUOTE OF THE DAY

"As many dialysis patients in this region seek alternative treatments to in-center dialysis, we believe there is a real opportunity to advance home hemodialysis in the Netherlands."

—Roel Kuiper, managing director of the Dutch company Dirinco, which signed a distribution agreement with NxStage


RESOURCES
CURRENT ISSUE